NCT05935748 2025-11-12
Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc)
NiKang Therapeutics, Inc.
Phase 2 Terminated
Clinical Trials
23 trialsNCT04633278 2025-05-11
CMP-001 in Combination With Pembrolizumab in Subjects With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Regeneron Pharmaceuticals
Phase 2 Terminated
NCT04162873 2025-02-12
Celecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer
University of Utah
Phase 2 Terminated
NCT03396471 2024-04-18
Study of Pembrolizumab and Concurrent Radiation in Patients With Previously Treated Carcinoma of Unknown Primary
Hoosier Cancer Research Network
Phase 2 Terminated
NCT02213133 2023-01-26
STARRS
Karyopharm Therapeutics Inc
Phase 2 Terminated
NCT00671645 2020-10-19
Preoperative Combined RadioChemo-Molecular Target Therapy With Capecitabine, Bevacizumab, and Radiotherapy
Austrian Breast & Colorectal Cancer Study Group
Phase 2 Terminated
NCT03549338 2020-09-28
Sym004 Versus Futuximab or Modotuximab in Patients With mCRC
Symphogen A/S
Phase 2 Terminated
NCT00672009 2018-10-24
A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer
Cedars-Sinai Medical Center
Phase 2 Terminated
NCT00804830 2018-08-28
Avastin and Doxorubicin Postoperatively for Patients With Anaplastic Thyroid Cancer
Region Skane
Phase 2 Terminated
NCT00417287 2018-05-16
Phase II Study of PX-12 in Patients With Advanced Pancreatic Cancer
Seagen Inc.
Phase 2 Terminated
NCT02473094 2017-11-28
NEOMETRE
University of Campinas, Brazil
Phase 2 Terminated
NCT01184053 2017-06-14
NRR
UNC Lineberger Comprehensive Cancer Center
Phase 2 Terminated
NCT00576056 2017-02-15
Effectiveness and Safety Study of TACE Plus Oral Sorafenib for Unresectable HCC
University of Pittsburgh
Phase 2 Terminated
NCT00318110 2016-07-26
Matched Unrelated Donor Transplant for Metastatic Renal Cell Carcinoma
Center for International Blood and Marrow Transplant Research
Phase 2 Terminated
NCT00975039 2016-04-18
Study Using WST11 in Patients With Non-Resectable or Inoperable Cholangiocarcinoma
Steba Biotech S.A.
Phase 2 Terminated
NCT01175772 2015-06-23
Maintenance Treatment for Ovarian Carcinoma in Remission by an Antiangiogenic Treatment Strategy
HaEmek Medical Center, Israel
Phase 2 Terminated
NCT01215578 2015-04-30
NET
Assistance Publique - Hôpitaux de Paris
Phase 2 Terminated
NCT00564876 2015-02-23
TOP0706
Duke University
Phase 2 Terminated
NCT01215565 2014-03-13
Fibrolam
Assistance Publique - Hôpitaux de Paris
Phase 2 Terminated
NCT00989092 2014-01-29
Darbepoetin Alfa and Anemia of Cancer
Amgen
Phase 2 Terminated
NCT01097083 2014-01-14
Coriolus Versicolor as Palliative Therapy Compared to Placebo in Patients With Child-Pugh C Unresectable Hepatocellular Carcinoma
National University Hospital, Singapore
Phase 2 Terminated
NCT00365183 2013-10-31
Trial of Motexafin Gadolinium and Pemetrexed (Alimta®) for Second Line Treatment in Patients With Non-Small Cell Lung Cancer
Pharmacyclics LLC.
Phase 2 Terminated
NCT00100685 2012-04-27
Study of M200 (Volociximab) in Patients With Metastatic Renal Cell Carcinoma (RCC)
Abbott
Phase 2 Terminated